Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain Metastases
SUH, John H, STEA, Baldassarre, SHAW, Edward, NABID, Abdenour, KRESL, John J, FORTIN, André, MERCIER, Jean-Philippe, SENZER, Neil, CHANG, Eric L, BOYD, Adam P, CAGNONI, Pablo J
Published in Journal of clinical oncology (01.01.2006)
Published in Journal of clinical oncology (01.01.2006)
Get full text
Journal Article
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, Julian D, Gane, Ed, Taubel, Jorg, Kao, Justin, Fontana, Marianna, Maitland, Michael L, Seitzer, Jessica, O’Connell, Daniel, Walsh, Kathryn R, Wood, Kristy, Phillips, Jonathan, Xu, Yuanxin, Amaral, Adam, Boyd, Adam P, Cehelsky, Jeffrey E, McKee, Mark D, Schiermeier, Andrew, Harari, Olivier, Murphy, Andrew, Kyratsous, Christos A, Zambrowicz, Brian, Soltys, Randy, Gutstein, David E, Leonard, John, Sepp-Lorenzino, Laura, Lebwohl, David
Published in The New England journal of medicine (05.08.2021)
Published in The New England journal of medicine (05.08.2021)
Get full text
Journal Article
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
Monk, Bradley J, Grisham, Rachel N, Banerjee, Susana, Kalbacher, Elsa, Mirza, Mansoor Raza, Romero, Ignacio, Vuylsteke, Peter, Coleman, Robert L, Hilpert, Felix, Oza, Amit M, Westermann, Anneke, Oehler, Martin K, Pignata, Sandro, Aghajanian, Carol, Colombo, Nicoletta, Drill, Esther, Cibula, David, Moore, Kathleen N, Christy-Bittel, Janna, Del Campo, Josep M, Berger, Regina, Marth, Christian, Sehouli, Jalid, O'Malley, David M, Churruca, Cristina, Boyd, Adam P, Kristensen, Gunnar, Clamp, Andrew, Ray-Coquard, Isabelle, Vergote, Ignace
Published in Journal of clinical oncology (10.11.2020)
Published in Journal of clinical oncology (10.11.2020)
Get full text
Journal Article
Impact of iron formulations on topramezone injury to bermudagrass
Boyd, Adam P., McElroy, J. Scott, Han, David Y., Guertal, Elizabeth A.
Published in Weed technology (01.06.2021)
Published in Weed technology (01.06.2021)
Get full text
Journal Article
Reducing topramezone injury to bermudagrass using chelated iron and other additives
Boyd, Adam P., McElroy, J. Scott, McCurdy, James D., McCullough, Patrick E., Han, David Y., Guertal, Elizabeth A.
Published in Weed technology (01.04.2021)
Published in Weed technology (01.04.2021)
Get full text
Journal Article
Phase II Multicenter Study of Induction Chemotherapy Followed by Concurrent Efaproxiral (RSR13) and Thoracic Radiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer
CHOY, Hak, NABID, Abdenour, SPANOS, William, KREISMAN, Harvey, BOYD, Adam P, CAGNONI, Pablo J, CURRAN, Walter J, STEA, Baldassarre, SCOTT, Charles, ROA, Wilson, KLEINBERG, Larry, AYOUB, Joseph, SMITH, Colum, SOUHAMI, Luis, HAMBURG, Solomon
Published in Journal of clinical oncology (01.09.2005)
Published in Journal of clinical oncology (01.09.2005)
Get full text
Journal Article
Estimation of treatment effect under non-proportional hazards and conditionally independent censoring
Boyd, Adam P., Kittelson, John M., Gillen, Daniel L.
Published in Statistics in medicine (10.12.2012)
Published in Statistics in medicine (10.12.2012)
Get full text
Journal Article
Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival
Stea, Baldassarre, Suh, John H., Boyd, Adam P., Cagnoni, Pablo J., Shaw, Edward
Published in International journal of radiation oncology, biology, physics (15.03.2006)
Published in International journal of radiation oncology, biology, physics (15.03.2006)
Get full text
Journal Article
Phase 1b/2 study of binimetinib (BINI) in combination with nivolumab (NIVO) or NIVO plus ipilimumab (IPI) in patients (pts) with previously treated microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) with RAS mutation
Bendell, Johanna C., Kopetz, Scott, Middleton, Mark R., Eves, P. Taylor, Bozon, Viviana, Boyd, Adam P., Schellens, Jan H.M.
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article
Molecular results and potential biomarkers identified from MILO/ENGOT-ov11 phase 3 study of binimetinib versus physicians choice of chemotherapy (PCC) in recurrent low-grade serous ovarian cancer (LGSOC)
Grisham, Rachel N., Vergote, Ignace, Banerjee, Susana N., Drill, Esther N., Fabbro, Michel, Mirza, Mansoor Raza, Romero, Ignacio, Coleman, Robert L., Oza, Amit M., Hilpert, Felix, Moore, Kathleen N., Westermann, Anneke M., Aghajanian, Carol, Scambia, Giovanni, Boyd, Adam P., Cantey-Kiser, Jean, O'Malley, David M., Farley, John H., Colombo, Nicoletta, Monk, Bradley J.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Estimation of treatment effect under nonproportional hazards and conditionally independent censoring
Boyd, Adam P., Kittelson, John M., Gillen, Daniel L.
Published in Statistics in medicine (04.07.2012)
Published in Statistics in medicine (04.07.2012)
Get full text
Journal Article
The MILO (MEK inhibitor in low-grade serous ovarian cancer)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician’s choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
Monk, Bradley J., Grisham, Rachel N., Marth, Christian, Banerjee, Susana N., Hilpert, Felix, Coleman, Robert L., Pujade-Lauraine, Eric, Pignata, Sandro, Mirza, Mansoor Raza, Oza, Amit M., del Campo, Josep M., Oehler, Martin Klaus, James, Adam, Christy-Bittel, Janna, Barrett, Emma, Boyd, Adam P., Vergote, Ignace
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
The MEK Inhibitor in Low-Grade Serous Ovarian Cancer (MILO)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician’s choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
Monk, Bradley J., Grisham, Rachel N., Marth, Christian, Banerjee, Susana N., Hilpert, Felix, Coleman, Robert L., Pujade-Lauraine, Eric, Pignata, Sandro, Mirza, Mansoor Raza, Oza, Amit M., del Campo, Josep M., Oehler, Martin Klaus, James, Adam, Christy-Bittel, Janna, Barrett, Emma, Boyd, Adam P., Vergote, Ignace
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival
Stea, Baldassarre, Suh, John H., Boyd, Adam P. M.S., Cagnoni, Pablo J., Shaw, Edward
Published in International journal of radiation oncology, biology, physics (15.03.2006)
Published in International journal of radiation oncology, biology, physics (15.03.2006)
Get full text
Journal Article